EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Using the daily rate of rise in hemoglobin S to manage RBC depletion/exchange treatment in sickle cell disease

Kai Rogers iD, Mouaz Alsawas, James Chapman, Annette J Schlueter, Charles Michael Knudson iD

Transfusion · 2024

DOI: 10.1111/trf.17797 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Transfusion, 2024. Verfasst von Kai Rogers und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Iowa Health Care, Iowa City, Iowa, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Blood Component Removal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Red blood cell exchange is often used prophylactically in patients with sickle cell disease, with the goal to maintain hemoglobin S (HbS) below a target threshold level. We reviewed whether the daily “rate of rise” (RoR) in HbS that occurs between procedures can be used for patient management. For some patients not achieving their HbS goals despite efficient exchanges, the post‐procedure hematocrit (Hct) target is increased to potentially suppress HbS production. This case series explores the utility of this approach, other clinical uses of the daily RoR in HbS, and the factors that influence it. Study Design and Methods A total of 660 procedures from 24 patients undergoing prophylactic RBC depletion/exchange procedures were included. Laboratory values and clinical parameters were collected and used to calculate the daily RoR in HbS. Factors such as Hct or medications that might influence the RoR in HbS were evaluated.

Results

The RoR in HbS varied widely between patients but remained relatively stable within individuals. Surprisingly, this value was not significantly influenced by changes in post‐procedure Hct or concurrent hydroxyurea use. A patient's average RoR in HbS effectively predicted the pre‐procedure HbS at the following visit ( R 2 = 0.65).

Discussion

The RoR in HbS is a relatively consistent parameter for individual patients that is unaffected by medication use or procedural Hct targets and may be useful in determining intervals between procedures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellBlood Component RemovalHumansHemoglobin, SickleErythrocyte TransfusionHematocrit

Stichwörter der Autor:innen

hemoglobinopathyred cell depletion/exchangesickle cell disease

Substanzen

Hemoglobin, Sickle

Autor:innen und Institutionen

  • Department of Pathology, University of Iowa Health Care, Iowa City, Iowa, USA.

ORCID-Profile: Kai Rogers, Charles Michael Knudson

Zitieren

APA

Rogers, K., Alsawas, M., Chapman, J., Schlueter, A. J., & Knudson, C. M. (2024). Using the daily rate of rise in hemoglobin S to manage RBC depletion/exchange treatment in sickle cell disease. Transfusion. https://doi.org/10.1111/trf.17797

Vancouver

Rogers K, Alsawas M, Chapman J, Schlueter AJ, Knudson CM. Using the daily rate of rise in hemoglobin S to manage RBC depletion/exchange treatment in sickle cell disease. Transfusion. 2024. doi:10.1111/trf.17797

BibTeX
@article{Rogers2024,
  author = {Rogers, Kai and Alsawas, Mouaz and Chapman, James and Schlueter, Annette J and Knudson, Charles Michael},
  title = {Using the daily rate of rise in hemoglobin S to manage RBC depletion/exchange treatment in sickle cell disease},
  journal = {Transfusion},
  year = {2024},
  doi = {10.1111/trf.17797}
}
Kostenlos starten →